{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T03:31:49Z","timestamp":1783999909849,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12013-024-01353-2","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T13:01:46Z","timestamp":1718456506000},"page":"2427-2437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Farrerol Alleviates Diabetic Cardiomyopathy by Regulating AMPK-Mediated Cardiac Lipid Metabolic Pathways in Type 2 Diabetic Rats"],"prefix":"10.1007","volume":"82","author":[{"given":"Jia","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huirong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luzhen","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,15]]},"reference":[{"key":"1353_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng, Y., Ley, S. H., & Hu, F. B. (2018). Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology, 14, 88\u201398.","journal-title":"Nature Reviews Endocrinology"},{"key":"1353_CR2","first-page":"411","volume":"55","author":"K Trachanas","year":"2014","unstructured":"Trachanas, K., Sideris, S., Aggeli, C., Poulidakis, E., Gatzoulis, K., Tousoulis, D., & Kallikazaros, I. (2014). Diabetic cardiomyopathy: from pathophysiology to treatment. Hellenic Journal of Cardiology, 55, 411\u2013421.","journal-title":"Hellenic Journal of Cardiology"},{"key":"1353_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12933-017-0506-x","volume":"16","author":"A Lorenzo-Almor\u00f3s","year":"2017","unstructured":"Lorenzo-Almor\u00f3s, A., Tu\u00f1\u00f3n, J., Orejas, M., Cort\u00e9s, M., Egido, J., & Lorenzo, \u00d3. (2017). Diagnostic approaches for diabetic cardiomyopathy. Cardiovascular Diabetology, 16, 28.","journal-title":"Cardiovascular Diabetology"},{"key":"1353_CR4","doi-asserted-by":"publisher","first-page":"1032268","DOI":"10.3389\/fendo.2022.1032268","volume":"13","author":"X Zhao","year":"2022","unstructured":"Zhao, X., Liu, S., Wang, X., Chen, Y., Pang, P., Yang, Q., Lin, J., Deng, S., Wu, S., Fan, G., & Wang, B. (2022). Diabetic cardiomyopathy: Clinical phenotype and practice. Frontiers in Endocrinology, 13, 1032268.","journal-title":"Frontiers in Endocrinology"},{"key":"1353_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11684-021-0881-2","volume":"16","author":"J Zhan","year":"2022","unstructured":"Zhan, J., Chen, C., Wang, D. W., & Li, H. (2022). Hyperglycemic memory in diabetic cardiomyopathy. Frontiers in Medicine, 16, 25\u201338.","journal-title":"Frontiers in Medicine"},{"key":"1353_CR6","doi-asserted-by":"publisher","first-page":"113525","DOI":"10.1016\/j.jpba.2020.113525","volume":"190","author":"X Xu","year":"2020","unstructured":"Xu, X., Luo, Z., He, Y., Shan, J., Guo, J., & Li, J. (2020). Application of untargeted lipidomics based on UHPLC-high resolution tandem MS analysis to profile the lipid metabolic disturbances in the heart of diabetic cardiomyopathy mice. Journal of Pharmaceutical and Biomedical Analysis, 190, 113525.","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"1353_CR7","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.jpha.2023.08.011","volume":"13","author":"Y Liu","year":"2023","unstructured":"Liu, Y., Zhang, X., Yang, S., Zhou, Z., Tian, L., Li, W., Wei, J., Abliz, Z., & Wang, Z. (2023). Integrated mass spectrometry imaging reveals spatial-metabolic alteration in diabetic cardiomyopathy and the intervention effects of ferulic acid. Journal of Pharmaceutical Analysis, 13, 1496\u20131509.","journal-title":"Journal of Pharmaceutical Analysis"},{"key":"1353_CR8","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.3390\/jcm11216544","volume":"11","author":"H Yaribeygi","year":"2022","unstructured":"Yaribeygi, H., Maleki, M., Reiner, \u017d., Jamialahmadi, T., & Sahebkar, A. (2022). Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu. Journal of Clinical Medicine, 11, 6544.","journal-title":"Journal of Clinical Medicine"},{"key":"1353_CR9","doi-asserted-by":"publisher","first-page":"114919","DOI":"10.1016\/j.biopha.2023.114919","volume":"164","author":"M Yan","year":"2023","unstructured":"Yan, M., Liu, S., Zeng, W., Guo, Q., Mei, Y., Shao, X., Su, L., Liu, Z., Zhang, Y., Wang, L., Diao, H., Rong, X., & Guo, J. (2023). The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice. Biomedicine and Pharmacotherapy, 164, 114919.","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"1353_CR10","doi-asserted-by":"publisher","first-page":"e023540","DOI":"10.1161\/JAHA.121.023540","volume":"11","author":"C Zhang","year":"2022","unstructured":"Zhang, C., Zhang, B., Zhang, X., Wang, M., & Sun, X. (2022). Panax notoginseng Saponin Protects Against Diabetic Cardiomyopathy Through Lipid Metabolism Modulation. Journal of the American Heart Association, 11, e023540.","journal-title":"Journal of the American Heart Association"},{"key":"1353_CR11","doi-asserted-by":"publisher","first-page":"e12763","DOI":"10.1111\/acel.12763","volume":"17","author":"L Wu","year":"2018","unstructured":"Wu, L., Wang, K., Wang, W., Wen, Z., Wang, P., Liu, L., & Wang, D. W. (2018). Glucagon-like peptide-1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPAR\u03b1 pathway. Aging Cell, 17, e12763.","journal-title":"Aging Cell"},{"key":"1353_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1152\/physrev.00011.2008","volume":"89","author":"GR Steinberg","year":"2009","unstructured":"Steinberg, G. R., & Kemp, B. E. (2009). AMPK in Health and Disease. Physiological Reviews, 89, 1025\u20131078.","journal-title":"Physiological Reviews"},{"key":"1353_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2217\/fon.09.174","volume":"6","author":"Z Luo","year":"2010","unstructured":"Luo, Z., Zang, M., & Guo, W. (2010). AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncology, 6, 457\u2013470.","journal-title":"Future Oncology"},{"key":"1353_CR14","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1111\/jcmm.14493","volume":"23","author":"Z Zheng","year":"2019","unstructured":"Zheng, Z., Ma, T., Guo, H., Kim, K. S., Kim, K. T., Bi, L., Zhang, Z., & Cai, L. (2019). 4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement. Journal of Cellular and Molecular Medicine, 23, 5771\u20135781.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"1353_CR15","doi-asserted-by":"publisher","first-page":"154002","DOI":"10.1016\/j.metabol.2019.154002","volume":"102","author":"Y Sun","year":"2020","unstructured":"Sun, Y., Zhou, S., Guo, H., Zhang, J., Ma, T., Zheng, Y., Zhang, Z., & Cai, L. (2020). Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function. Metabolism, 102, 154002.","journal-title":"Metabolism"},{"key":"1353_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.micpath.2018.04.051","volume":"131","author":"B Li","year":"2019","unstructured":"Li, B., Chen, P., Wang, J. H., Li, L., Gong, J. L., & Yao, H. (2019). Farrerol overcomes the invasiveness of lung squamous cell carcinoma cells by regulating the expression of inducers of epithelial mesenchymal transition. Microbial Pathogenesis, 131, 277.","journal-title":"Microbial Pathogenesis"},{"key":"1353_CR17","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3390\/ijms19061770","volume":"19","author":"Y Li","year":"2018","unstructured":"Li, Y., Gong, Q., Guo, W., Kan, X., Xu, D., Ma, H., Fu, S., & Liu, J. (2018). Farrerol Relieve Lipopolysaccharide (LPS)-Induced Mastitis by Inhibiting AKT\/NF-\u03baB p65, ERK1\/2 and P38 Signaling Pathway. International Journal of Molecular Sciences, 19, 1770.","journal-title":"International Journal of Molecular Sciences"},{"key":"1353_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.biopha.2018.10.053","volume":"109","author":"B Cui","year":"2019","unstructured":"Cui, B., Zhang, S., Wang, Y., & Guo, Y. (2019). Farrerol attenuates \u03b2-amyloid- induced oxidative stress and inflammation through Nrf2\/Keap1 pathway in a microglia cell line. Biomedicine and Pharmacotherapy, 109, 112\u2013119.","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"1353_CR19","doi-asserted-by":"publisher","first-page":"879232","DOI":"10.3389\/fphar.2022.879232","volume":"13","author":"L Zhou","year":"2022","unstructured":"Zhou, L., Yang, S., & Zou, X. (2022). Farrerol alleviates myocardial ischemia\/ reperfusion injury by targeting macrophages and NLRP3. Frontiers in Pharmacology, 13, 879232.","journal-title":"Frontiers in Pharmacology"},{"key":"1353_CR20","doi-asserted-by":"publisher","first-page":"1079251","DOI":"10.3389\/fphar.2022.1079251","volume":"13","author":"J He","year":"2022","unstructured":"He, J., Xu, D., Wang, L., & Yu, X. (2022). Farrerol prevents Angiotensin II-induced cardiac remodeling in vivo and in vitro. Frontiers in Pharmacology, 13, 1079251.","journal-title":"Frontiers in Pharmacology"},{"key":"1353_CR21","doi-asserted-by":"publisher","first-page":"788","DOI":"10.7150\/ijbs.30677","volume":"15","author":"L Wang","year":"2019","unstructured":"Wang, L., Wei, W., Xiao, Q., Yang, H., & Ci, X. (2019). Farrerol ameliorates APAP-induced hepatotoxicity via activation of Nrf2 and autophagy. International Journal of Biological Sciences, 15, 788\u2013799.","journal-title":"International Journal of Biological Sciences"},{"key":"1353_CR22","doi-asserted-by":"publisher","first-page":"110081","DOI":"10.1016\/j.biopha.2020.110081","volume":"127","author":"Z Wang","year":"2020","unstructured":"Wang, Z., Zhu, Y., Zhang, Y., Zhang, J., Ji, T., Li, W., & Li, W. (2020). Protective effects of AS-IV on diabetic cardiomyopathy by improving myocardial lipid metabolism in rat models of T2DM. Biomedicine and Pharmacotherapy, 127, 110081.","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"1353_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12933-019-0980-4","volume":"19","author":"M Arow","year":"2020","unstructured":"Arow, M., Waldman, M., Yadin, D., Nudelman, V., Shainberg, A., Abraham, N. G., Freimark, D., Kornowski, R., Aravot, D., & Hochhauser, E. (2020). Sodium- glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy. Cardiovascular Diabetology, 19, 7.","journal-title":"Cardiovascular Diabetology"},{"key":"1353_CR24","doi-asserted-by":"publisher","first-page":"864326","DOI":"10.3389\/fphar.2022.864326","volume":"13","author":"X Tian","year":"2022","unstructured":"Tian, X., Chen, X., Jiang, Q., Sun, Q., Liu, T., Hong, Y., Zhang, Y., Jiang, Y., Shao, M., Yang, R., Li, C., Wang, Q., & Wang, Y. (2022). Notoginsenoside R1 ameliorates cardiac lipotoxicity through AMPK signaling pathway. Frontiers in Pharmacology, 13, 864326.","journal-title":"Frontiers in Pharmacology"},{"key":"1353_CR25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4070\/kcj.2015.45.4.266","volume":"45","author":"S Yilmaz","year":"2015","unstructured":"Yilmaz, S., Canpolat, U., Aydogdu, S., & Abboud, H. E. (2015). Diabetic Cardiomyopathy; Summary of 41 Years. Korean Circulation Journal, 45, 266\u2013272.","journal-title":"Korean Circulation Journal"},{"key":"1353_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00059-010-3336-0","volume":"35","author":"B Stratmann","year":"2010","unstructured":"Stratmann, B., Gawlowski, T., & Tschoepe, D. (2010). Diabetic cardiomyopathy -to take a long story serious. Herz, 35, 161\u2013168.","journal-title":"Herz"},{"key":"1353_CR27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1177\/0960327112450885","volume":"32","author":"BR Goyal","year":"2013","unstructured":"Goyal, B. R., & Mehta, A. A. (2013). Diabetic cardiomyopathy: pathophysiological mechanisms and cardiac dysfuntion. Human and Experimental Toxicology, 32, 571\u2013590.","journal-title":"Human and Experimental Toxicology"},{"key":"1353_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10741-021-10200-y","volume":"28","author":"FR Prandi","year":"2023","unstructured":"Prandi, F. R., Evangelista, I., Sergi, D., Palazzuoli, A., & Romeo, F. (2023). Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants. Heart Failure Reviews, 28, 597\u2013606.","journal-title":"Heart Failure Reviews"},{"key":"1353_CR29","doi-asserted-by":"publisher","first-page":"H241","DOI":"10.1152\/ajpheart.00390.2022","volume":"324","author":"A Velagic","year":"2023","unstructured":"Velagic, A., & Li, M. (2023). A high-sucrose diet exacerbates the left ventricular phenotype in a high fat-fed streptozotocin rat model of diabetic cardiomyopathy. American Journal of Physiology-Heart and Circulatory Physiology, 324, H241\u2013h257.","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"1353_CR30","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1002\/ptr.7175","volume":"35","author":"Y Li","year":"2021","unstructured":"Li, Y., Wei, X., Liu, S. L., Zhao, Y., Jin, S., & Yang, X. Y. (2021). Salidroside protects cardiac function in mice with diabetic cardiomyopathy via activation of mitochondrial biogenesis and SIRT3. Phytotherapy Research, 35, 4579\u20134591.","journal-title":"Phytotherapy Research"},{"key":"1353_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3892\/mmr.2021.11854","volume":"23","author":"Q Jin","year":"2021","unstructured":"Jin, Q., Zhu, Q., Wang, K., Chen, M., & Li, X. (2021). Allisartan isoproxil attenuates oxidative stress and inflammation through the SIRT1\/Nrf2\/NF\u2011\u03baB signalling pathway in diabetic cardiomyopathy rats. Mol Med Rep, 23, 215.","journal-title":"Mol Med Rep"},{"key":"1353_CR32","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1248\/bpb.b17-00724","volume":"41","author":"Q Wang","year":"2018","unstructured":"Wang, Q., Liu, S., Zhai, A., Zhang, B., & Tian, G. (2018). AMPK-Mediated Regulation of Lipid Metabolism by Phosphorylation. Biol Pharm Bull, 41, 985\u2013993.","journal-title":"Biol Pharm Bull"},{"key":"1353_CR33","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2023.0031","author":"SS Li","year":"2024","unstructured":"Li, S. S., Pan, L., Zhang, Z. Y., Zhou, M. D., Chen, X. F., Qian, L. L., Dai, M., Lu, J., Yu, Z. M., Dang, S., & Wang, R. X. (2024). Diabetes promotes myocardial fibrosis via AMPK\/EZH2\/PPAR-\u03b3 signaling pathway. Diabetes and Metabolism Journal. https:\/\/doi.org\/10.4093\/dmj.2023.0031.","journal-title":"Diabetes and Metabolism Journal"},{"key":"1353_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04942-0","volume":"22","author":"J Dong","year":"2024","unstructured":"Dong, J., Li, M., Peng, R., Zhang, Y., Qiao, Z., & Sun, N. (2024). ACACA reduces lipid accumulation through dual regulation of lipid metabolism and mitochondrial function via AMPK- PPAR\u03b1- CPT1A axis. Journal of Translational Medicine, 22, 196.","journal-title":"Journal of Translational Medicine"},{"key":"1353_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.physbeh.2011.02.029","volume":"105","author":"C Martin","year":"2011","unstructured":"Martin, C., Chevrot, M., Poirier, H., Passilly-Degrace, P., Niot, I., & Besnard, P. (2011). CD36 as a lipid sensor. Physiology and Behavior, 105, 36\u201342.","journal-title":"Physiology and Behavior"},{"key":"1353_CR36","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.bbalip.2016.03.018","volume":"1861","author":"TT Kim","year":"2016","unstructured":"Kim, T. T., & Dyck, J. R. (2016). The role of CD36 in the regulation of myocardial lipid metabolism. Biochimica et Biophysica Acta, 1861, 1450\u20131460.","journal-title":"Biochimica et Biophysica Acta"},{"key":"1353_CR37","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1152\/physrev.00011.2023","volume":"104","author":"JFC Glatz","year":"2024","unstructured":"Glatz, J. F. C., & Heather, L. C. (2024). CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease. Physiological Reviews, 104, 727\u2013764.","journal-title":"Physiological Reviews"},{"key":"1353_CR38","doi-asserted-by":"publisher","first-page":"112556","DOI":"10.1016\/j.jep.2020.112556","volume":"255","author":"Q Yang","year":"2020","unstructured":"Yang, Q., Shu, F., Gong, J., Ding, P., Cheng, R., Li, J., Tong, R., Ding, L., Sun, H., Huang, W., Wang, Z., & Yang, L. (2020). Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response. Journal of Ethnopharmacology, 255, 112556.","journal-title":"Journal of Ethnopharmacology"},{"key":"1353_CR39","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3724\/abbs.2021023","volume":"54","author":"H Yang","year":"2022","unstructured":"Yang, H., Zhao, H., Ren, Z., Yi, X., Zhang, Q., Yang, Z., Kuang, Y., & Zhu, Y. (2022). Overexpression CPT1A reduces lipid accumulation via PPAR\u03b1\/CD36 axis to suppress the cell proliferation in ccRCC. Acta Biochimica et Biophysica Sinica, 54, 220\u2013231.","journal-title":"Acta Biochimica et Biophysica Sinica"},{"key":"1353_CR40","doi-asserted-by":"publisher","first-page":"1228646","DOI":"10.3389\/fphar.2023.1228646","volume":"14","author":"MW Song","year":"2023","unstructured":"Song, M. W., Cui, W., Lee, C. G., Cui, R., Son, Y. H., Kim, Y. H., Kim, Y., Kim, H. J., Choi, S. E., Kang, Y., Kim, T. H., Jeon, J. Y., & Lee, K. W. (2023). Protective effect of empagliflozin against palmitate-induced lipotoxicity through AMPK in H9c2 cells. Frontiers in Pharmacology, 14, 1228646.","journal-title":"Frontiers in Pharmacology"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01353-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01353-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01353-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T14:22:20Z","timestamp":1727792540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01353-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1353"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01353-2","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,15]]},"assertion":[{"value":"4 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All animal research adhered to protocols approved by the Wuhan Cloud-Clone Technology Co., Ltd (approval number: IACU22-1089).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Authors give full consent to participate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Authors give full consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}